relative to data collection and reporting requirements of the prescription drug affordability board.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 5 Sponsors 3

Mar 13, 2025 · House

Lay HB 645 on Table (Rep. Osborne): MA VV 03/13/2025 HJ 8 P. 78

Mar 3, 2025 · House

Executive Session: 02/05/2025 11:30 am LOB 210-211

Mar 3, 2025 · House

Committee Report: Ought to Pass with Amendment # 2025-0505h 02/19/2025 (Vote 17-0; RC)

Jan 29, 2025 · House

Public Hearing: 02/05/2025 11:30 am LOB 210-211

Jan 21, 2025 · House

Introduced (in recess of) 01/09/2025 and referred to Health, Human Services and Elderly Affairs HJ 3 P. 21

PASSAGE PROBABILITY

40.6% Uncertain

Why this number

Stage base Reported from Committee — base rate 47%, measured from NH's completed sessions
Momentum -1 46/100 from the pace of recorded action
Time since last action -22 576 days quiet
Cosponsors +3 2 signed on
Bipartisan support +9 1 D · 2 R
Sponsor influence +5 95/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.